Liu Y, Yang J
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Kidney Int. 2006 Jul;70(2):238-40. doi: 10.1038/sj.ki.5001661.
Hepatocyte growth factor (HGF) has emerged as a potent, endogenous antifibrotic factor that shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft nephropathy.
肝细胞生长因子(HGF)已成为一种强效的内源性抗纤维化因子,在多种动物模型中,它在改善组织纤维化方面显示出令人瞩目的功效。埃雷罗 - 弗雷斯内达等人提供了新的证据,证明肌肉注射HGF基因可降低慢性移植肾肾病的死亡率、炎症和肾纤维化。